PMID- 37883927
OWN - NLM
STAT- MEDLINE
DCOM- 20231220
LR  - 20231220
IS  - 1423-0399 (Electronic)
IS  - 0042-1138 (Linking)
VI  - 107
IP  - 10-12
DP  - 2023
TI  - Needle-Perc-Assisted Endoscopic Surgery in Treatment with Renal Staghorn Stones: 
      A Prospective Randomized Controlled Study from a Large-Volume Stone Center.
PG  - 910-915
LID - 10.1159/000533955 [doi]
AB  - INTRODUCTION: The goal of this study was to evaluate the efficacy and safety of 
      needle-perc-assisted endoscopic surgery (NAES) in the treatment of staghorn renal 
      stones via a single-center prospective randomized controlled study. METHODS: A 
      total of 219 patients with partial or complete staghorn renal stones were 
      prospectively randomized into two groups between January 2020 and April 2022. In 
      group A (n = 112), patients were treated with traditional standard access, 
      multiple if necessary, and in group B (n = 107), only one standard access was 
      made, and needle-perc was assisted to remove the residual stones in the same 
      stage. All procedures were guided under ultrasound totally. Stone size, operating 
      time, blood loss, pain score, complications, and other related characteristics 
      were monitored and analyzed. RESULTS: Procedures were successful in all patients. 
      The baseline characters were similar between the groups. The mean stone size was 
      comparable (4.5 +/- 1.4 vs. 4.7 +/- 1.7, p = 0.35). The 1-month stone-free status was 
      achieved in 85 patients (75.9%) in group A and 80 (74.8%) patients in group B (p 
      = 0.72). The operation time was shorter in group A than B (75.1 +/- 28.1 min vs. 
      97.2 +/- 20.4 min, p = 0.02). A less blood loss (p = 0.01), shorter hospital stay 
      (p = 0.04), lower pain score (p = 0.04), and lower severe complication rates (p = 
      0.03) were observed in group B. CONCLUSION: NAES reveals better postoperative 
      recurrence compared with traditional multiple tracts method for treating staghorn 
      renal stones. The stone-free rate was comparable between the two groups.
CI  - (c) 2023 S. Karger AG, Basel.
FAU - Xiao, Bo
AU  - Xiao B
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China.
FAU - Diao, Xiaolin
AU  - Diao X
AD  - Department of Medicine, Peking University Hospital, Beijing, China.
FAU - Zeng, Xue
AU  - Zeng X
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China, 
      cengx12@tsinghua.org.cn.
FAU - Jin, Song
AU  - Jin S
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China.
FAU - Zhang, Gang
AU  - Zhang G
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China.
FAU - Bai, Wenjie
AU  - Bai W
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China.
FAU - Li, Jianxing
AU  - Li J
AD  - Department of Urology, Tsinghua University Affiliated Beijing Tsinghua Changgung 
      Hospital, Tsinghua University Clinical Institute, Beijing, China.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20231026
PL  - Switzerland
TA  - Urol Int
JT  - Urologia internationalis
JID - 0417373
SB  - IM
MH  - Humans
MH  - Prospective Studies
MH  - *Nephrolithotomy, Percutaneous/methods
MH  - *Kidney Calculi/surgery
MH  - *Staghorn Calculi/surgery
MH  - Pain
MH  - Treatment Outcome
MH  - Retrospective Studies
MH  - *Nephrostomy, Percutaneous
OTO - NOTNLM
OT  - Kidney
OT  - Needle-Perc
OT  - Percutaneous nephrolithotomy
OT  - Staghorn
OT  - Stone
EDAT- 2023/10/27 00:43
MHDA- 2023/12/20 06:42
CRDT- 2023/10/26 18:22
PHST- 2023/03/15 00:00 [received]
PHST- 2023/08/07 00:00 [accepted]
PHST- 2023/12/20 06:42 [medline]
PHST- 2023/10/27 00:43 [pubmed]
PHST- 2023/10/26 18:22 [entrez]
AID - 000533955 [pii]
AID - 10.1159/000533955 [doi]
PST - ppublish
SO  - Urol Int. 2023;107(10-12):910-915. doi: 10.1159/000533955. Epub 2023 Oct 26.